Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EPS (Weighted Average and Diluted)Shares Outstanding (Weighted Average)
Others
Ratios

China SXT Pharmaceuticals (SXTC) Operating Expenses: 2020-2023

  • China SXT Pharmaceuticals' Operating Expenses was N/A to $164.1 billion in Q3 2023 from the same period last year, while for Sep 2023 it was $164.1 billion, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2025, which is 0.69% down from last year.
  • As of Q3 2023, China SXT Pharmaceuticals' Operating Expenses stood at $164.1 billion, which was up 71,141,251.50% from $230,642 recorded in Q1 2023.
  • In the past 5 years, China SXT Pharmaceuticals' Operating Expenses ranged from a high of $296.0 billion in Q3 2020 and a low of $180,370 during Q1 2021.
  • Over the past 2 years, China SXT Pharmaceuticals' median Operating Expenses value was $212,742 (recorded in 2021), while the average stood at $41.0 billion.
  • Data for China SXT Pharmaceuticals' Operating Expenses shows a maximum YoY crashed of 100.00% (in 2021) over the last 5 years.
  • China SXT Pharmaceuticals' Operating Expenses (Quarterly) stood at $296.0 billion in 2020, then plummeted by 100.00% to $194,841 in 2021, then reached $164.1 billion in 2023.
  • Its Operating Expenses stands at $164.1 billion for Q3 2023, versus $230,642 for Q1 2023 and $194,841 for Q3 2021.